2seventy bio vs Autolus Therapeutics
2seventy bio
It’s about time we think smarter and faster than cancer
122 employees · est. 2021 · Cambridge, United States
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer
720 employees · est. 2014 · London, United Kingdom
Autolus Therapeutics is the older company (2021 vs 2014); Autolus Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | 2seventy bio | Autolus Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2014 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | London, United Kingdom |
| Employees | ||
| Employees | 122 | 720 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Acquired | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $614.62M | $1.07B |
| Funding Rounds | ||
| Funding Rounds | 4 | 10 |
| Services | ||
| Services | Research & Development, Clinical Trials, Product Development, Scientific Resources Provision, Medicines Access and Support | Development of autologous T cell therapies, Advanced cell programming, Manufacturing of T cells, Clinical trial management, Pipeline products for cancer and autoimmune diseases |
| Target Customers | ||
| Target Customers | Patients with Cancer, Patients with Hematological Diseases, Neurological and Psychiatric Patients, Healthcare Providers, Patient Advocacy Groups, Medical Researchers | Patients with cancer and autoimmune diseases, Healthcare professionals, Investors interested in biotech innovations, Research institutions |
| Taxonomy | ||
| Taxonomy | Immuno-oncologyCell TherapyCancer TreatmentCancer Cell MetabolismGenomicsImmune Response +8 | CAR T Cell TherapyT Cell ProgrammingCancer TreatmentAutologous T Cell TherapiesNext-generation TherapiesObe-cel (obecabtagene Autoleucel) +9 |
| Website | ||
| Website | 2seventybio.com | autolus.com |
About 2seventy bio
2seventy bio is a progressive player in the field of immuno-oncology cell therapy, founded in 2021. With its headquarters in the United States, the company is dedicated to altering the future of cancer treatment. Their innovative approach is encapsulated in the slogan, "It’s about time we think smar...
About Autolus Therapeutics
Autolus Therapeutics, founded in 2014, is a pioneering company in the Biopharma, Biotechnology, and Pharmaceutical industries. Based in the United Kingdom, the company is renowned for its innovative approach towards cancer treatment, with a clear focus on developing precisely targeted and highly con...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches 2seventy bio and Autolus Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when 2seventy bio or Autolus Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare 2seventy bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at 2seventy bio on 3 Jul 2026, and Autolus Therapeutics on 1 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
